1 |
5 asa, enemas, suppositories, corticosteroids |
- |
- |
- |
- |
097 [1] 97 💬 |
2 |
Acei/arb and corticosteroids |
- |
- |
- |
- |
066 [1] 66 💬 |
3 |
Azithromycin + n-acetylcystein + inhaled corticosteroid |
Azithromycin |
[3] D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
228 [1] 228 💬 |
4 |
Chronic corticosteroid therapy |
- |
- |
- |
- |
113 [1] 113 💬 |
5 |
Combined plasma exchange (pex), rituximab, and corticosteroids |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
085 [1] 85 💬 |
6 |
Corticosteroid |
- |
- |
- |
- |
013 [10] 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
7 |
Corticosteroid (cs) |
- |
- |
- |
- |
041 [1] 41 💬 |
8 |
Corticosteroid (prednisolone) |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
9 |
Corticosteroid and azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
042 [4] 42, 43, 44, 45 💬 |
10 |
Corticosteroid and non-biological agents. |
- |
- |
- |
- |
046 [1] 46 💬 |
11 |
Corticosteroid or nsaid |
- |
- |
- |
- |
046 [1] 46 💬 |
12 |
Corticosteroid treatment (methylprednisolone or prednisolone) |
Methylprednisolone |
[14] D00407 D00407, D00472 D00472, D00751 D00751, D00979 D00979, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
064 [1] 64 💬 |
13 |
Corticosteroids |
- |
- |
- |
- |
041 [10] 41, 46, 49, 64, 97, 107, 164, 220, 296, 300 💬 |
14 |
Corticosteroids & tancart19/20 |
- |
- |
- |
- |
013 [1] 13 💬 |
15 |
Corticosteroids (aprednislon) |
- |
- |
- |
- |
063 [1] 63 💬 |
16 |
Corticosteroids (prednisone or prednisolone) |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
17 |
Corticosteroids for systemic use |
- |
- |
- |
- |
041 [1] 41 💬 |
18 |
Corticosteroids only |
- |
- |
- |
- |
097 [1] 97 💬 |
19 |
Corticosteroids'therapy |
- |
- |
- |
- |
035 [1] 35 💬 |
20 |
Cs (corticosteroids) only |
- |
- |
- |
- |
097 [1] 97 💬 |
21 |
Cumulative corticosteroid exposure |
- |
- |
- |
- |
049 [1] 49 💬 |
22 |
Iv corticosteroid |
- |
- |
- |
- |
097 [1] 97 💬 |
23 |
Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone |
Mesalazine |
[7] D00377 D00377, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
24 |
Oral corticosteroids |
- |
- |
- |
- |
013 [3] 13, 46, 97 💬 |
25 |
Oral corticosteroids (ocs) |
- |
- |
- |
- |
162 [1] 162 💬 |
26 |
Treatment with topical superpotent corticosteroid therapy |
- |
- |
- |
- |
162 [1] 162 💬 |
27 |
Valproid acid plus corticosteroids |
- |
- |
- |
- |
026 [1] 26 💬 |